Guglielmone A A, Lugaresi C I, Volpogni M M, Anziani O S, Vanzini V R
Instituto Nacional de Tecnología Agropecuaria, Estación Experimental Agropecuaria Rafaela, Rafaela (Santa Fe), Argentina.
Vet Parasitol. 1997 Jun;70(1-3):33-9. doi: 10.1016/s0304-4017(96)01143-0.
The efficacy of vaccination of Argentinean cattle against babesiosis and anaplasmosis using live immunogens was tested to detect specific antibodies in samples obtained about 60 days after vaccination. Under these conditions a higher than expected proportion of cattle failed to show antibodies against Babesia bigemina. Therefore, a study was designed to evaluate if this failure was due to insensitivity of the routine test to detect antibodies to B. bigemina or to lack of infectivity of the live vaccine. Four groups (G) of cattle were each inoculated subcutaneously with 10 million Babesia bovis (vaccinal strain R1A), 10 million B. bigemina (vaccinal strain S1A) and 10 million Anaplasma centrale (strain M1). G1 and G2 consisted of ten Angus bulls 20-24 months old and ten Angus bulls 15-18 months old, respectively; G3 and G4 consisted of ten and 16 Holstein 1-month-old male calves, respectively. Blood samples were obtained on days 0, 10, 20, 30, 40, 50 and 60 after vaccination and the sera were analysed with an indirect immunofluorescent (IFA) test to detect antibodies to B. bovis (baseline dilution for a positive result 1:60) and B. bigemina (baseline dilution 1:120). Positive IFA titres were considered as evidence of the infectivity of the Babesia vaccinal strains contained in the vaccine. All Angus bulls were found positive to antibodies against both Babesia species, by day 20 (B. bovis) and day 30 (B. bigemina), whereas 10-25% of Holstein calves were negative throughout. The partial lack of vaccine infectivity in the calves was considered to be a consequence of innate resistance of young calves to Babesia. Antibody titres to B. bovis and B. bigemina declined by day 60 after vaccination. However, all cattle that were positive to B. bovis antibodies on day 50 were still positive to the IFA test 10 days later while 10%, 30% and 12% of cattle of G1, G2 and G3 that were positive to B. bigemina antibodies on day 50 after vaccination were found negative to the IFA test on day 60. In future, samples taken on days 40-50 will be used for detection of B. bigemina antibodies in vaccinated cattle, on day 60 for A. centrale and on either occasion for B. bovis. The reaction to the inoculation of B. bigemina S1A strain appears to lag behind the reaction to B. bovis R1A strain. It is not certain if this is a normal reaction to this B. bigemina strain or the result of interaction with the B. bovis strain.
对阿根廷牛使用活免疫原接种疫苗预防巴贝斯虫病和无形体病的效果进行了检测,以在接种疫苗约60天后采集的样本中检测特异性抗体。在这些条件下,未显示针对双芽巴贝斯虫抗体的牛的比例高于预期。因此,设计了一项研究来评估这种失败是由于常规检测对检测双芽巴贝斯虫抗体不敏感,还是由于活疫苗缺乏感染力。四组牛分别皮下接种1000万个牛巴贝斯虫(疫苗株R1A)、1000万个双芽巴贝斯虫(疫苗株S1A)和1000万个中央无形体(菌株M1)。G1和G2分别由10头20 - 24月龄的安格斯公牛和10头15 - 18月龄的安格斯公牛组成;G3和G4分别由10头和16头1月龄的荷斯坦雄性犊牛组成。在接种疫苗后的第0、10、20、30、40、50和60天采集血样,并用间接免疫荧光(IFA)试验分析血清,以检测针对牛巴贝斯虫(阳性结果的基线稀释度为1:60)和双芽巴贝斯虫(基线稀释度为1:120)的抗体。IFA阳性滴度被视为疫苗中所含巴贝斯虫疫苗株具有感染力的证据。到第20天(牛巴贝斯虫)和第30天(双芽巴贝斯虫)时,所有安格斯公牛均被发现针对两种巴贝斯虫的抗体呈阳性,而10 - 25%的荷斯坦犊牛自始至终均为阴性。犊牛中疫苗部分缺乏感染力被认为是幼犊对巴贝斯虫具有先天抵抗力的结果。接种疫苗后第60天,针对牛巴贝斯虫和双芽巴贝斯虫的抗体滴度下降。然而,在第50天对牛巴贝斯虫抗体呈阳性的所有牛在10天后的IFA试验中仍为阳性,而接种疫苗后第50天对双芽巴贝斯虫抗体呈阳性的G1、G2和G3组的牛中,分别有10%、30%和12%在第60天的IFA试验中被发现为阴性。未来,将在第40 - 50天采集的样本用于检测接种疫苗的牛中的双芽巴贝斯虫抗体,在第60天检测中央无形体抗体,在任何一种情况下检测牛巴贝斯虫抗体。对双芽巴贝斯虫S1A株接种的反应似乎滞后于对牛巴贝斯虫R1A株的反应。尚不确定这是对该双芽巴贝斯虫株的正常反应还是与牛巴贝斯虫株相互作用的结果。